Abstract:Coronaviruses are a major healthcare threat to humankind. Currently, the host factors that contribute to limit disease severity in healthy young patients are not well defined. Interferons are key antiviral molecules, especially type I and type III interferons. The role of these interferons during coronavirus disease is a subject of debate. Here using mice that are deficient in type I (IFNAR1 -/- ), type III (IFNLR1 -/- ) or both (IFNAR1/LR1 -/- ) interferon signaling pathways and murine adapted coronavirus (MHV-A59) administered through intranasal route, we define the role of interferons in coronavirus infection. We show that type I interferons play a major role in host survival in this model while a minimal role of type III interferons was manifested only in the absence of type I interferons or during a lethal dose of coronavirus. IFNAR1 -/- and IFNAR1/LR1 -/- mice had an uncontrolled viral burden in the airways and lung and increased viral dissemination to other organs. The absence of only type III interferon signaling had no measurable difference in the viral load. The increased viral load in IFNAR1 -/- and IFNAR1/LR1 -/- mice was associated with increased tissue injury, especially evident in the lung and liver. Type I but not type III interferon treatment was able to promote survival if treated during early disease. Further, we show that type I interferon signaling in macrophages contributes to the beneficial effects during coronavirus infection in mice. Importance: The antiviral and pathological potential of type I and type III interferons during coronavirus infection remains poorly defined and opposite findings have been reported. We report that both type I and type III interferons have anti-coronaviral activities, but their potency and organ specificity differ. Type I interferons deficiency rendered the mice susceptible to even a sublethal murine coronavirus infection, while the type III interferon deficiency impaired survival only during a lethal infection or during a sublethal infection in absence of type I interferon signaling. While treatment with both type I and III interferons promoted viral clearance in the airways and lung, only type I interferons promoted the viral clearance in the liver and improved host survival upon early treatment (12 hours post infection). This study demonstrates distinct roles and potency of type I and type III interferons and their therapeutic potential during coronavirus lung infection.

Phospholipase A2 Group IID is Indispensable for Coronavirus-Specific Humoral Immune Memory in Middle Aged Mice

Coronavirus-specific Antibody Production in Middle-Aged Mice Requires Phospholipase A2G2D.

SHP2 Deficiency Promotes Staphylococcus Aureus Pneumonia Following Influenza Infection

Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (Sars-Cov) Infection in Senescent BALB/c Mice: CD4+T Cells Are Important in Control of SARS-CoV Infection

Eicosanoid Signalling Blockade Protects Middle-Aged Mice from Severe COVID-19

Bioinformatic analysis of PD 1 checkpoint blockade responsive immune microenvironment in severe influenza infection

Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections

Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease

Tissue resident memory T cells contribute to protectionagainst heterologousSARS-CoV-2 challenge

Alveolar epithelial cells orchestrate DC function in murine viral pneumonia

Distinct Roles of Type I and Type III Interferons During a Native Murine β Coronavirus Lung Infection

Genomic Analysis Reveals Age-Dependent Innate Immune Responses to Severe Acute Respiratory Syndrome Coronavirus

The IL-33/ST2 signaling axis drives pathogenesis in acute SARS-CoV-2 infection

Innate memory against viruses

COVID-19 and influenza infections mediate distinct pulmonary cellular and transcriptomic changes

Eicosanoid Signaling As a Therapeutic Target in Middle-Aged Mice with Severe COVID-19

Genetic absence of PD-L1 does not restore CD8+ T cell function during respiratory virus infection and delays virus clearance

Transgenic CCL2 expression in the central nervous system results in a dysregulated immune response and enhanced lethality after coronavirus infection

Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19

The Papain-like Protease Domain of Severe Acute Respiratory Syndrome Coronavirus 2 Conjugated with Human Beta-Defensin 2 and Co1 Induces Mucosal and Systemic Immune Responses against the Virus

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice